We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-16.79%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$122M
AUM Growth
-$51.2M
Cap. Flow
+$8.31M
Cap. Flow %
6.81%
Top 10 Hldgs %
86.85%
Holding
31
New
12
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
OR icon
OR Royalties Inc
OR
+$2.21M
2
APLT
Applied Therapeutics
APLT
+$2.2M
3
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$726K
4
SA
Seabridge Gold
SA
+$600K
5
FNV icon
Franco-Nevada
FNV
+$557K

Top Sells

Rank Stock Value
1
OTRK
Ontrak
OTRK
+$1.1M
2
AVXL icon
Anavex Life Sciences
AVXL
+$445K

Sector Composition

Rank Sector Weight
1 Healthcare 84.25%
2 Materials 6.78%
3 Communication Services 1.82%
4 Financials 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$55.7M 45.68%
857,494
– –
APLT
2
DELISTED
Applied Therapeutics
APLT
$15.3M 12.5%
734,980
+84,742
+13% +$2.2M
CRBP icon
3
Corbus Pharmaceuticals
CRBP
$173M
$9.08M 7.44%
168,196
– –
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.84M 3.97%
19,841
+2,333
+13% +$726K
ALDX icon
5
Aldeyra Therapeutics
ALDX
$94.1M
$4.22M 3.46%
569,405
– –
ABEO icon
6
Abeona Therapeutics
ABEO
$352M
$2.92M 2.39%
114,391
– –
AVXL icon
7
Anavex Life Sciences
AVXL
$234M
$2.83M 2.32%
620,789
-103,416
-14% -$445K
XCUR icon
8
Exicure
XCUR
$11.2M
$2.24M 1.83%
8,519
– –
LUMN icon
9
Lumen
LUMN
$6.43B
$2.22M 1.82%
220,000
– –
ENTX icon
10
Entera Bio
ENTX
$188M
$2.16M 1.77%
1,741,363
– –
BX icon
11
Blackstone
BX
$105B
$2.09M 1.71%
40,000
– –
DOW icon
12
Dow Inc
DOW
$20.8B
$1.42M 1.16%
30,000
– –
SNGX icon
13
Soligenix
SNGX
$5.34M
$1.41M 1.16%
3,286
– –
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
$1.24M 1.02%
7,594
– –
BTAI icon
15
BioXcel Therapeutics
BTAI
$26.6M
$867K 0.71%
1,250
– –
CTVA icon
16
Corteva
CTVA
$58.3B
$864K 0.71%
30,000
– –
DD icon
17
DuPont de Nemours
DD
$18.7B
$832K 0.68%
11,950
– –
SA
18
Seabridge Gold
SA
$2.82B
$601K 0.49%
+32,000
New +$600K
MMX
19
DELISTED
Maverix Metals Inc. Common Shares
MMX
$591K 0.48%
+115,000
New +$539K
AEM icon
20
Agnico Eagle Mines
AEM
$73.2B
$549K 0.45%
+6,900
New +$527K
EQX icon
21
Equinox Gold
EQX
$7.47B
$533K 0.44%
+45,500
New +$548K
KL
22
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$524K 0.43%
+10,750
New +$539K
FNV icon
23
Franco-Nevada
FNV
$41.5B
$523K 0.43%
+3,750
New +$557K
OR icon
24
OR Royalties Inc
OR
$5.54B
$496K 0.41%
+190,000
New +$2.21M
MAG
25
DELISTED
MAG Silver
MAG
$281K 0.23%
+17,300
New +$277K
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Knoll Capital Management held 31 positions worth $122M, down 30% from $173M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Knoll Capital Management deployed $8.31M of net new capital in Q3 2020, opening 12 new positions and adding to 2 existing holdings. Its largest new stake was OR Royalties Inc: 190,000 shares worth $496K.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 91% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Anavex Life Sciences, an estimated $445K trimmed.

  • Knoll Capital Management's largest Q3 2020 buy was OR Royalties Inc: 190,000 shares worth $496K.
  • Knoll Capital Management added most to Applied Therapeutics in Q3 2020, an estimated $2.2M increase.
  • Knoll Capital Management's biggest Q3 2020 reduction was Anavex Life Sciences, cutting an estimated $445K.
  • Knoll Capital Management fully exited Ontrak in Q3 2020, selling an estimated $1.1M.
  • Knoll Capital Management's ten largest holdings make up 87% of its $122M portfolio in Q3 2020.
  • Knoll Capital Management opened 12 new positions and closed 1 in Q3 2020.
  • Knoll Capital Management's portfolio value fell 30% quarter-over-quarter to $122M.

Based on Knoll Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.